Ipsen Presents Comprehensive Data Showing ‘Survival Benefit’ In Pancreatic Cancer In Phase 3 Trial by Technical Terrence Team 01/20/2023 0 gorodenkoff Ipsen (OTCPK:IPSEY) (OTCPK:IPSEF) presented complete data from a Phase 3 trial showing that its drug Onivyde helped improve overall ...
Albireo Pharma (NASDAQ:ALBO) Downgraded Following Ipsen Acquisition Proposal by Technical Terrence Team 01/11/2023 0 Nastassia Samal Biopharmaceutical company Albireo Pharma (NASDAQ: WHITE) as a reaction to its agreement to be acquired by the French ...